PhRMA Seeks US FDA Rationale For Rx Drug Advertising Studies
Trade association says research projects are often unnecessary, questions studies of low-internet users and how disclosures about a product affect viewer perceptions.
You may also be interested in...
US FDA responds to comments on proposed study of product disclosures and study of amount and location of risk information.
Upcoming research projects will look at presentation of FDA approval status, timing of disease awareness ads, and healthcare professional views.
Last year's record low five letters came as FDA launched flurry of studies on DTC, professional ads; 'Bad Ad' complaints totaled more than 100.